January 31, 2023 Comments Off on New patent for Beigene drug BRUKINSA Posted in: Patent Added Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent for Beigene drug BRUKINSA appeared first on DrugPat…
January 31, 2023 Comments Off on New patent for Allergan drug DALVANCE Posted in: Patent Added Annual Drug Patent Expirations for DALVANCE Dalvance is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent for Allergan drug DALVANCE appeared first on DrugP…